Company news
Cyclerion Therapeutics, Inc. news in 2023
Cyclerion Therapeutics, Inc.'s news releases, calls and decks from 2023, newest first.
Cyclerion Appoints Regina Graul, Ph.D., as President
December 3, 2023
Cyclerion Strengthens Board of Directors with Experienced Company Builder and Cutting-edge Innovator
November 29, 2023
Cyclerion Regains Compliance with Nasdaq Minimum Bid Price Requirement
May 31, 2023
Cyclerion Announces Reverse Stock Split
May 14, 2023
Cyclerion Announces Definitive Agreement for Zagociguat and CY3018
May 10, 2023
Cyclerion Announces Corporate Updates and Q1 2023 Financial Results
May 10, 2023
Cyclerion Therapeutics Enters into Exclusive Negotiation Period and Binding Equity Investment Agreement
April 2, 2023
Cyclerion Therapeutics Receives U.S. FDA Orphan Drug Designation for Zagociguat for the Treatment of Mitochondrial Diseases
March 26, 2023
Cyclerion Reports Corporate Update and Full Year 2022 Financial Results
March 21, 2023